These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30616415)

  • 1. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
    Kemps PG; Cleven AHG; van Wezel T; van Eijk R; Bot FJ; Veelken H; van Balen P; Kerkhoffs JH
    Am J Hematol; 2020 Nov; 95(11):1427-1429. PubMed ID: 32243611
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
    Breese EH; Krupski C; Nelson AS; Perentesis JP; Phillips CL
    J Pediatr Hematol Oncol; 2021 May; 43(4):152-154. PubMed ID: 32496443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pediatric case of
    Murphy L; Siegele B; Carstens B; Hartman L; Faulk K
    Leuk Lymphoma; 2024 Jun; 65(6):843-847. PubMed ID: 38372299
    [No Abstract]   [Full Text] [Related]  

  • 5. Extramedullary relapse of
    Aldoss I; Song JY
    Blood; 2018 May; 131(22):2507. PubMed ID: 29853461
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of constitutive activation of FMS-related tyrosine kinase-3 and
    Fedders H; Alsadeq A; Schmäh J; Vogiatzi F; Zimmermann M; Möricke A; Lenk L; Stadt UZ; Horstmann MA; Pieters R; Schrappe M; Stanulla M; Cario G; Schewe DM
    Haematologica; 2017 Nov; 102(11):e438-e442. PubMed ID: 28838992
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in
    Adriaanse FRS; Schneider P; Arentsen-Peters STCJM; Fonseca AMND; Stutterheim J; Pieters R; Zwaan CM; Stam RW
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
    Burmeister T; Ströh AS; Kehden B; Trautmann H; Meyer C; Marschalek R; Larghero P; Schwartz S; Steffen B; Spriewald B; Heinicke T; Jäkel N; Westermann J; Nachtkamp K; Viardot A; Topp MS; Neumann M; Baldus CD; Gökbuget N; Brüggemann M
    Leukemia; 2024 Jul; 38(7):1600-1603. PubMed ID: 38519799
    [No Abstract]   [Full Text] [Related]  

  • 10. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
    Permikin Z; Popov A; Verzhbitskaya T; Riger T; Plekhanova O; Makarova O; Froňková E; Trka J; Meyer C; Marschalek R; Tsaur G; Fechina L
    Leuk Res; 2022 Jan; 112():106758. PubMed ID: 34864370
    [No Abstract]   [Full Text] [Related]  

  • 11. Romidepsin enhances the efficacy of cytarabine
    Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
    Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
    [No Abstract]   [Full Text] [Related]  

  • 12. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
    Rayes A; McMasters RL; O'Brien MM
    Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
    Ferrari A; Ghelli Luserna Di Rora A; Domizio C; Papayannidis C; Simonetti G; Maria Hernández-Rivas J; Rondoni M; Giglio F; Abruzzese E; Imovilli A; Iacobucci I; Calistri D; Martinelli G
    Br J Haematol; 2021 Mar; 192(6):e139-e144. PubMed ID: 33314053
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in
    Wölfl M; Rasche M; Eyrich M; Schmid R; Reinhardt D; Schlegel PG
    Blood Adv; 2018 Jun; 2(12):1382-1385. PubMed ID: 29898879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement.
    Zoghbi A; Zur Stadt U; Winkler B; Müller I; Escherich G
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.
    Sarkar S; Rav E; Stitzlein L; Gibson A; McCall D; Nunez C; Roth M; Ragoonanan D; Connors J; Herzog CE; Cuglievan B; Garcia MB
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30964. PubMed ID: 38514796
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get?
    Menendez P; Bueno C
    Leuk Res; 2011 Aug; 35(8):989-90. PubMed ID: 21492935
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-induced Deletion in 11q23 Leading to Fusion of
    Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of allogeneic hematopoietic stem cell transplantation in KMT2A-rearranged acute leukemia].
    Liu J; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):514-520. PubMed ID: 38964931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.